Ying H Shen Selected Research

Thoracic Aorta Dissection

6/2014	Matrix metalloproteinase levels in chronic thoracic aortic dissection.
5/2009	Thoracic aortic dissection: are matrix metalloproteinases involved?
7/2006	Increased collagen deposition and elevated expression of connective tissue growth factor in human thoracic aortic dissection.
5/2006	A single nucleotide polymorphism in the matrix metalloproteinase 9 gene (-8202A/G) is associated with thoracic aortic aneurysms and thoracic aortic dissection.
8/2005	Decreased expression of fibulin-5 correlates with reduced elastin in thoracic aortic dissection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ying H Shen Research Topics

Disease

8	Inflammation (Inflammations) 01/2021 - 03/2006
7	Aortic Dissection 01/2022 - 05/2009
7	Rupture 01/2022 - 08/2008
6	Aortic Aneurysm (Aneurysm, Aortic) 01/2022 - 08/2007
6	Thoracic Aortic Aneurysm 10/2020 - 05/2006
5	Aneurysm (Aneurysms) 11/2021 - 06/2014
5	Thoracic Aorta Dissection 06/2014 - 08/2005
5	Atherosclerosis 01/2011 - 02/2006
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2011 - 03/2006
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 05/2010 - 03/2006
4	Vascular Diseases (Vascular Disease) 11/2021 - 12/2005
4	Aortic Diseases 01/2020 - 05/2006
3	Mitochondrial Diseases (Mitochondrial Disease) 11/2021 - 01/2018
3	Atherosclerotic Plaque (Atheroma) 01/2021 - 08/2008
3	Bites and Stings (Sting) 01/2020 - 01/2017
3	Pulmonary Embolism 05/2017 - 12/2009
2	Hemorrhage 01/2022 - 05/2017
2	Coronary Artery Disease (Coronary Atherosclerosis) 11/2021 - 04/2005
2	Abdominal Aortic Aneurysm 01/2021 - 10/2018
2	Fibrosis (Cirrhosis) 09/2013 - 04/2010
2	Insulin Resistance 08/2006 - 03/2006
2	Infections 05/2006 - 02/2006
1	Marfan Syndrome (Marfan's Syndrome) 01/2022
1	Disease Progression 01/2022
1	Ascending Aorta Aneurysm 12/2021
1	Neoplasms (Cancer) 11/2021
1	Turner Syndrome (Turner's Syndrome) 01/2021
1	Pulmonary Arterial Hypertension 01/2021
1	Right Ventricular Hypertrophy 01/2021
1	Vascular Remodeling 01/2021
1	Venous Thrombosis (Deep-Vein Thrombosis) 07/2020
1	Thrombosis (Thrombus) 07/2020
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2019
1	Pulmonary Hypertension 01/2019
1	Hemoptysis 01/2019
1	Atrial Fibrillation 11/2018
1	Atrial Premature Complexes (Premature Atrial Contraction) 11/2018
1	Diabetes Mellitus 05/2017
1	Aortic Rupture 01/2017
1	Obesity 01/2017
1	Hyperglycemia 01/2017
1	Hypertension (High Blood Pressure) 06/2014

Drug/Important Bio-Agent (IBA)

7	Angiotensin IIIBA 01/2021 - 02/2013
5	Nonesterified Fatty Acids (NEFA)IBA 01/2017 - 08/2006
4	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 04/2005
4	CytokinesIBA 10/2018 - 03/2006
4	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 03/2006 - 04/2005
3	RNA (Ribonucleic Acid)IBA 12/2021 - 01/2021
3	InflammasomesIBA 01/2020 - 01/2017
3	InterferonsIBA 01/2020 - 01/2017
3	Matrix Metalloproteinases (MMPs)IBA 01/2018 - 05/2009
3	CollagenIBA 08/2008 - 07/2006
2	Ciprofloxacin (Cipro)FDA LinkGeneric 01/2022 - 01/2018
2	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 01/2022 - 01/2018
2	FluoroquinolonesIBA 01/2022 - 01/2018
2	CholesterolIBA 01/2021 - 01/2020
2	N- (1,2,3,5,6,7- hexahydro- S- indacen- 4- ylcarbamoyl)- 4- (2- hydroxy- 2- propanyl)- 2- furansulfonamideIBA 01/2020 - 11/2018
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2020 - 05/2006
2	Contractile ProteinsIBA 01/2020 - 01/2017
2	Mitochondrial DNA (mtDNA)IBA 01/2020 - 01/2018
2	Interferon Regulatory Factor-3 (Interferon Regulatory Factor 3)IBA 01/2020 - 01/2017
2	ElastinIBA 01/2019 - 08/2005
2	Peptide Hydrolases (Proteases)FDA Link 01/2017 - 05/2006
2	Messenger RNA (mRNA)IBA 02/2013 - 12/2005
2	CadmiumIBA 01/2011 - 09/2009
2	Proteins (Proteins, Gene)FDA Link 04/2010 - 12/2005
2	Insulin (Novolin)FDA Link 08/2006 - 03/2006
1	Transforming Growth Factor-beta Type II ReceptorIBA 01/2022
1	Small Cytoplasmic RNAIBA 12/2021
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 11/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2021
1	Adenosine Triphosphate (ATP)IBA 11/2021
1	NAD (NADH)IBA 11/2021
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2021
1	MonocrotalineIBA 01/2021
1	Plasminogen Activator Inhibitor 2IBA 01/2021
1	Protein Isoforms (Isoforms)IBA 01/2021
1	Mitogen-Activated Protein Kinase 14IBA 01/2021
1	N-acetylVal-Nle(7,8)- allatotropin (5-13) (ATAA)IBA 10/2020
1	Phosphotransferases (Kinase)IBA 07/2020
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020
1	Proteoglycans (Proteoglycan)IBA 10/2019
1	AntibodiesIBA 01/2019
1	LeptinIBA 10/2018
1	ApolipoproteinsIBA 10/2018
1	Topoisomerase InhibitorsIBA 01/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018
1	A-Form DNA (A-DNA)IBA 01/2018
1	AnticoagulantsIBA 05/2017
1	Metalloproteases (Metalloproteinases)IBA 01/2017
1	Palmitic Acid (Hexadecanoic Acid)IBA 01/2017
1	DisintegrinsIBA 01/2017
1	ThrombospondinsIBA 01/2017
1	Caspase 1 (ICE Protease)IBA 01/2017
1	NucleotidesIBA 01/2017
1	fibrin fragment D (D-dimer)IBA 09/2014
1	Biomarkers (Surrogate Marker)IBA 06/2014
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 09/2013

Therapy/Procedure

6	Therapeutics 01/2022 - 08/2007
1	Ligation 07/2020